Abbott Laboratories vs. Xenon Pharmaceuticals Inc
Abbott Laboratories and Xenon Pharmaceuticals Inc are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | XENE | |
|---|---|---|
| Market Cap | $189.28 billion | $3.79 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | XENE | |
|---|---|---|
| Dividend Yield | 2.31% | — |
ABT and XENE split the dividend factors evenly.
Risk & Sentiment
| ABT | XENE | |
|---|---|---|
| Short Interest | 0.57% | 0.15% |
XENE leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, XENE overview, XENE financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.